A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investigated in participants with type 1 diabetes. The study will look at how well insulin icodec taken weekly controls blood sugar compared to insulin glargine taken daily. The study will last for about 8.5 months.
Inclusion Criteria:
Exclusion Criteria:
clinicaltrials@novonordisk.com(+1) 866-867-7178
Loma Linda, California 92354, United States
Los Angeles, California 90015, United States
Santa Clarita, California 91321, United States
Englewood, Colorado 80113, United States
Englewood, Colorado 80113, United States
Morehead City, North Carolina 28557, United States
Philadelphia, Pennsylvania 19107, United States
Chattanooga, Tennessee 37411, United States
Fort Worth, Texas 76132, United States
San Antonio, Texas 78233, United States
Macquarie Park, New South Wales 2109, Australia
Wollongong, New South Wales 2500, Australia
Oaklands Park, South Australia 5046, Australia
Fitzroy, Victoria 3065, Australia
Parkville, Victoria 3050, Australia
Eisenach, 99817, Germany
Hamburg, 22041, Germany
Münster, 48153, Germany
Saint Ingbert-Oberwürzbach, 66386, Germany
Krakow, Lesser Poland Voivodeship 31-261, Poland
Legnica, Lower Silesian Voivodeship 59-220, Poland
Opole, 45-301, Poland
Poznan, 60-354, Poland
Zabrze, 41-800, Poland
Brasov, 500283, Romania
Constanța, 900591, Romania